Hopp til hovedinnhold

Sarkoidose

Sist revidert:
Sist revidert av:
Definisjon:
Idiopatisk, granulomatøs systemsykdom som oftest affiserer lunger og intratorakale lymfeknuter, men også ekstratorakale manifestasjoner er hyppige
Forekomst:
Usikre tall, tilstanden er ofte asymptomatisk. Insidens er 5-18 per 100.000 per år. Debuterer hyppigst i aldersgruppen 30-55 år 
Symptomer:
30-50% er symptomfrie og oppdages ved et tilfeldig rtg. thorax. Symptomatisk sykdom debuterer enten akutt eller smygende. Hoste, tungpusthet, diffuse brystsmerter, ev. slitenhet og sykdomsfølelse
Funn:
Alle organer kan affiseres, men hyppigst lunger, hud, lymfeknuter, lever. Som regel få eller ingen organiske funn
Diagnostikk:
Finnes ingen definitiv diagnostisk test. Røntgen, ev. CT, blodprøver, histologi
Behandling:
Selvhelbredende hos en god del pasienter. Ved progressiv sykdom behandles med kortikosteroider, ev. immunsupprimerende eller biologiske medisiner, ev. transplantasjon
  1. Soto-Gomez N, Peters JI. Diagnosis and management of sarcoidosis. Am Fam Physician. 2016 May 15;93(10):840-850.
  2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357: 2153-65. PubMed  
  3. Shinn J, Paauw DS. The Management of Sarcoidosis: A Primary Care Approach. Med Clin North Am. 2015;99:1123-48. doi: 10.1016/j.mcna.2015.05.008 DOI  
  4. Milman N, Mortensen SAa. Kardial sarkoidose. Ugeskr Læger 2006; 168: 3801-5. PubMed  
  5. Stavem K. Sarkoidose. Norsk legemiddelhåndbok, sist oppdatert 20.07.2020. www.legemiddelhandboka.no  
  6. Boeck C. Multiple benign sarcoid of the skin. J Cutan Genitourin Dis 1899; 17: 543-50. PubMed  
  7. King TE. Treatment of pulmonary sarcoidosis: Initial therapy with glucocorticoids. UpToDate, last updated Jan 25, 2017. UpToDate  
  8. Arkema EV, Cozier YC. Epidemiology of sarcoidosis: current findings and future directions. Ther Adv Chronic Dis 2018; 9(11): 227-240. pmid:30364496 PubMed  
  9. Voortman M, Drent M, Baughman RP. Management of neurosarcoidosis: a clinical challenge. Curr Opin Neurol. 2019;32(3):475-483. PMID: 30865007 PubMed  
  10. King TE. Clinical manifestations and diagnosis of pulmonary sarcoidosis. UpToDate, last updated Aug 06, 2019. www.uptodate.com  
  11. Valeyre D, Prasse A, Nunes H, et al. Sarcoidosis. Lancet. 2014 Mar 29;383(9923):1155-67. pmid: 24090799 PubMed  
  12. Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305–1323.
  13. Kouranos V, Sharma R. Cardiac sarcoidosis: state-of-the-art review. Heart 2021. doi:10.1136/heartjnl-2019-316442 DOI  
  14. Norsk forening for lungemedisin: Faglige retningslinjer for sarkoidose. Norsk sarkoidoseforening, 2019. Oversatt fra Svensk Lungmedicinsk Förenings Vårdprogram för Sarkoidos 2014 (0ppdatert 2018). Oversetter: Trond Bjørge. sarkoidose.no  
  15. Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J. Sarcoidosis published correction appears in Nat Rev Dis Primers. 2019 Jul 16;5(1):49. Nat Rev Dis Primers. 2019;5(1):45. PMID: 31273209 PubMed  
  16. Grunewald J, Eklund A. Sex-specific manifestations of Löfgren's syndrome. Am J Respir Crit Care Med 2007; 175(1): 40-4. pmid:17023727 PubMed  
  17. Sand M, Sand D, Thrandorf C. Cutaneous lesions of the nose. Head Face Med 2010. pmid:20525327 PubMed  
  18. Idali F, Wikén M, Wahlström J, et al. Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis. Eur Respir J 2006; 27: 451-9. PubMed  
  19. Dempsey OJ, Paterson EW, Kerr KM, Denison AR. Sarcoidosis. Clinical review. BMJ 2009; 339: b3206. BMJ (DOI)  
  20. Bonfioli AA, Orefice F. Sarcoidosis. Semin Ophthalmol 2005; 20: 177-82. PubMed  
  21. Tan JL, Fong HK, Birati EY, Han Y. Cardiac Sarcoidosis. Am J Cardiol. 2019;123(3):513-522. PMID: 30503798 PubMed  
  22. Spencer TS, Campellone JV, Maldonado I, Huang N, Usmani Q, Reginato AJ. Clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Semin Arthritis Rheum 2005; 34: 649-61. PubMed  
  23. Eurelings LEM, Miedema JR, Dalm VASH, et al. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis. PLoS One. 2019;14(10):e0223897. Published 2019 Oct 17. doi:10.1371/journal.pone.0223897 DOI  
  24. Ungprasert P, Carmona EM, Crowson CS, Matteson EL. Diagnostic Utility of Angiotensin-Converting Enzyme in Sarcoidosis: A Population-Based Study. Lung 2016; 194:91. PubMed  
  25. Thillai M, Atkins CP, Crawshaw A, et al. BTS Clinical Statement on pulmonary sarcoidosis. Thorax 2021; 76:4. PubMed  
  26. Nunes H, Brillet PY, Valeyre D, Brauner MW, Wells AU. Imaging in sarcoidosis. Semin Respir Crit Care Med 2007; 28: 102-20. PubMed  
  27. Sobic-Saranovic D, Artiko V, Obradovic V. FDG PET imaging in sarcoidosis. Semin Nucl Med. 2013;43(6):404–411.
  28. Annema JT, Veseliç M, Rabe KF. Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of sarcoidosis. Eur Respir J 2005; 25: 405-9. PubMed  
  29. von Bartheld MB, Dekkers OM, Szlubowski A, et al. Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial. JAMA. 2013;309(23):2457–2464.
  30. Kamangar N. Sarcoidosis. Medscape, last updated Jun 20, 2019. emedicine.medscape.com  
  31. Pawate S. Sarcoidosis and the Nervous System. Continuum (Minneap Minn). 2020;26(3):695-715. PMID: 32487903 PubMed  
  32. Paramothayan NS, Lasserson TJ, Jones P. Corticosteroids for pulmonary sarcoidosis. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD001114. DOI: 10.1002/14651858.CD001114.pub2. DOI  
  33. Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU. Pulmonary sarcoidosis. Lancet Respir Med. 2018;6(5):389-402. PMID: 29625772 PubMed  
  34. Muthiah MP, Gamal AE. Sarcoidosis. BMJ Best Practice, last updated 28 Mar 2018. bestpractice.bmj.com  
  35. Baughman RP, Lower EE. Treatment of Sarcoidosis. Clin Rev Allergy Immunol. 2015;49(1):79-92. PubMed  
  36. Baughman RP, Costabel U, du Bois RM. Treatment of sarcoidosis. Clin Chest Med 2008; 29: 533. PubMed  
  37. Al-Kofahi K, Korsten P, Ascoli C, et al. Management of extrapulmonary sarcoidosis: challenges and solutions. Ther Clin Risk Manag. 2016;12:1623-1634. Published 2016 Nov 7. PMID: 27853374 PubMed  
  38. Yang SJ, Salek S, Rosenbaum JT. Ocular sarcoidosis: new diagnostic modalities and treatment. Curr Opin Pulm Med. 2017;23(5):458-467. PubMed  
  39. Weill D, Benden C, Corris PA, et al. A consensus document for the selection of lung transplant candidates: 2014—an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015;34(1):1–15.
  40. Ungprasert P, Crowson CS, Matteson EL.   Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013. Eur Respir J. 2017. PMID: 28182567 PubMed  
  41. Rossides M, Kullberg S, Askling J et al. Sarcoidosis mortality in Sweden: a population-based cohort study. Eur Respir J 2018. pmid:29467203 PubMed  
  • Peter Jost, spesialist i allmennmedisin, redaktør NEL, Trondheim
  • Terje Johannessen, professor i allmennmedisin, Trondheim

Tidligere fagmedarbeidere

  • Hasse Melbye, spesialist i allmennmedisin, førsteamanuensis ved institutt for samfunnsmedisin, Universitetet i Tromsø
  • Helge Bjørnstad Pettersen, overlege/førsteamanuensis, Lungeavdelingen, Regionsykehuset i Trondheim og Norges Teknisk Naturvitenskapelige Universitet, Trondheim